For example, the most studied fusion in prostate cancer is formed between the TMPRSS2 and ERG genes, resulting in ERG transcription being driven by the androgen-responsive TMPRSS2 promoter [6–8]. This evidence concerns the gene TMPRSS2 and Familial prostate cancer.